C07D517/04

ORGANIC COMPOUND AND ELECTROLUMINESCENT DEVICE CONTAINING THE SAME

An organic compound having the structure of Formula (I), shown below, is disclosed. When used in a hole injection layer or a hole transporting layer, it can greatly improve the balance of electron holes and electron transporting of a device, thereby bringing excellent device effects, for example, improving the efficiency and lifetime of a device. At the same time, it also achieves a good effect when the organic compound having the structure of Formula (I) is used as a P-type conductive doping material in a charge generation layer of a multi-layer OLED device.

##STR00001##

ORGANIC COMPOUND AND ELECTROLUMINESCENT DEVICE CONTAINING THE SAME

An organic compound having the structure of Formula (I), shown below, is disclosed. When used in a hole injection layer or a hole transporting layer, it can greatly improve the balance of electron holes and electron transporting of a device, thereby bringing excellent device effects, for example, improving the efficiency and lifetime of a device. At the same time, it also achieves a good effect when the organic compound having the structure of Formula (I) is used as a P-type conductive doping material in a charge generation layer of a multi-layer OLED device.

##STR00001##

Proteasome Inhibiting Beta-Lactam Produrgs Useful for the Treatment of Cancer and Nurodegenerative Disorders

The present invention relates generally to proteasome inhibiting -lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.

Proteasome Inhibiting Beta-Lactam Produrgs Useful for the Treatment of Cancer and Nurodegenerative Disorders

The present invention relates generally to proteasome inhibiting -lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.

NOVEL ISOTHIAZOLO-BASED BICYCLES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS

The invention relates to the technical field of the herbicides and/or plant growth regulators. Specifically, the invention primarily relates to novel substituted isothiazolopyridones, and compositions comprising said novel substituted isothiazolopyridones. Further, the present invention relates to processes for the preparation said novel substituted isothiazolopyridones and their use as herbicides and/or plant growth regulators.

COMPOUND AND ORGANIC THIN FILM AND THIN FILM TRANSISTOR AND ELECTRONIC DEVICE

Disclosed are a compound represented by Chemical Formula 1A or 1B, an organic thin film including the same, a thin film transistor, and an electronic device.

##STR00001##

In Chemical Formula 1A or 1B, X.sup.1, X.sup.2, Ar.sup.1, R.sup.1 to R.sup.4, and n.sub.1 are the same as described in the detailed description.

COMPOUND AND THIN FILM TRANSISTOR AND ELECTRONIC DEVICE

Disclosed are a compound represented by Chemical Formula 1A or 1B, an organic thin film, a thin film transistor, and an electronic device.

##STR00001##

In Chemical Formulae 1A and 1B, X.sup.1, Ar.sup.13 , R.sup.1 to R.sup.4, and n.sub.1 are the same as described in the detailed description.

COMPOUND AND THIN FILM TRANSISTOR AND ELECTRONIC DEVICE

Disclosed are a compound represented by Chemical Formula 1A or 1B, an organic thin film, a thin film transistor, and an electronic device.

##STR00001##

In Chemical Formulae 1A and 1B, X.sup.1, Ar.sup.13 , R.sup.1 to R.sup.4, and n.sub.1 are the same as described in the detailed description.

Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof

A method of synthesizing a fused heteroaromatic compound includes obtaining a first intermediate from a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, obtaining a second intermediate including a ring having a chalcogen element from the first intermediate, and obtaining a fused heteroaromatic compound by a cyclization reaction of the second intermediate.

Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof

A method of synthesizing a fused heteroaromatic compound includes obtaining a first intermediate from a first compound represented by Chemical Formula 1 and a second compound represented by Chemical Formula 2, obtaining a second intermediate including a ring having a chalcogen element from the first intermediate, and obtaining a fused heteroaromatic compound by a cyclization reaction of the second intermediate.